HFA Premium Access

A pre-specified, participant-level pooled analysis of PARAGON-HF and PARAGLIDE-HF

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Congress Presentation

About the speaker

Doctor Muthiah Vaduganathan

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)
20 presentations
5 followers

4 more presentations in this session

PARAGLIDEHF: Sacubitril/Valsartan versus valsartan on changes in NTproBNP, safety, and tolerability in patients with EF>40% stabilized after a WHF Event

Speaker: Doctor R. Mentz (Durham, US)

Thumbnail

STEP HFpEF trial design and baseline characteristics

Speaker: Doctor M. Kosiborod (Kansas City, US)

Thumbnail

DAPA-RESIST clinical trial - Dapagliflozin versus metolazone in heart failure with diuretic resistance

Speaker: Doctor R. Campbell (Glasgow, GB)

Thumbnail

Verinurad plus allopurinol for heart failure with preserved ejection fraction: results from the AMETHYST randomized controlled trial

Speaker: Professor A. Voors (Groningen, NL)

Thumbnail

Access the full session

Late breaking clinical trials: medical therapy

Speakers: Doctor M. Vaduganathan, Doctor R. Mentz, Doctor M. Kosiborod, Doctor R. Campbell, Professor A. Voors
Thumbnail

About the event

Image

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb